American College of Cardiology and Boehringer Ingelheim collaborate to advance physician education with focus on China in 2013
11 March 2013 | By Boehringer Ingelheim
International peer-to-peer sharing...
List view / Grid view
11 March 2013 | By Boehringer Ingelheim
International peer-to-peer sharing...
11 March 2013 | By Abbott
Abbott announced positive long-term results...
11 March 2013 | By BASF
BASF Pharma Callanish has received approval to sell concentrated omega-3 fatty acids as active pharmaceutical ingredients...
11 March 2013 | By Catalent Pharma Solutions
Catalent announced two joint ventures...
11 March 2013 | By Boehringer Ingelheim
New data presented...
10 March 2013 | By Pfizer
Results from the REMINDER trial...
10 March 2013 | By Gilead Sciences
Gilead Sciences announced data from the Phase 4 TERISA study...
10 March 2013 | By Abbott
Data from the EVEREST II study...
9 March 2013 | By Merck
Results from the HPS2-THRIVE study...
7 March 2013 | By GlaxoSmithKline
GlaxoSmithKline announced the submission of a Marketing Authorisation Application for albiglutide...
7 March 2013 | By Biosector 2
NovoPen® 5 has just been approved for launch in China...
7 March 2013 | By B&W Tek
B&W Tek, Inc. is proud to announce the i-Raman® EX portable Raman spectrometer...
7 March 2013 | By Merck
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories (MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role…
6 March 2013 | By GlaxoSmithKline
24-week data from Phase III SAILING study...
6 March 2013 | By Roche
Viral load test uses a novel dual-probe approach designed to manage patients being treated with antiviral therapies...